CIK 0001863127 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Net income (USD) | -119.9 M | -69.1 M | -55.3 M |
| Diluted EPS (USD/shares) | -2.01 | -1.62 | -1.32 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-21 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-09-17 | 4 | 4 | 2026-09-15 |
| 2026-09-17 | 4 | 4 | 2026-09-15 |
| 2026-09-17 | 4 | 4 | 2026-09-15 |
| 2026-09-17 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-09-17 | 4 | 4 | 2026-09-15 |
| 2026-09-17 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-09-15 | 8-K | 8-K items 8.01,9.01 | 2026-09-14 |
| 2026-09-15 | 424B5 | 424B5 | |
| 2026-09-14 | FWP | FWP | |
| 2026-09-14 | S-3ASR | S-3ASR | |
| 2026-09-11 | 4 | 4 | 2026-09-09 |
| 2026-09-09 | 8-K | 8-K items 8.01 | 2026-09-09 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-04 | 424B5 | 424B5 | |
| 2026-08-04 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-04 | 8-K | 8-K items 2.02,9.01 | 2026-08-04 |
| 2026-07-30 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-06-26 | 144 | 144 | |
| 2026-06-02 | 8-K | 8-K items 5.07 | 2026-05-28 |
| 2026-06-01 | 4 | 4 | 2026-05-28 |
| 2026-06-01 | 4 | 4 | 2026-05-28 |
| 2026-06-01 | 4 | 4 | 2026-05-28 |
| 2026-06-01 | 4 | 4 | 2026-05-28 |
Forms on file (last 1,000): 4 171, 144 49, 8-K 46, 3 31, SCHEDULE 13G/A 15, 10-Q 15, SCHEDULE 13G 10, SC 13D/A 10. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=TYRA (0.002 USD), /gw/filings/filings?ticker=TYRA&form=8-K, /gw/filings/facts?ticker=TYRA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange